What is the recommended starting dose of buspirone (Buspar) for an adult?

Recommended Starting Dose of Buspirone (Buspar)

The recommended starting dose of buspirone for adults is 5 mg twice daily (total 10 mg/day), which can be increased by 5 mg/day every 2-3 days as tolerated until reaching the typical therapeutic range of 15-30 mg/day in divided doses. 1

Dosing Algorithm

Initial Dosing

• Start: 5 mg twice daily (morning and evening)
• This conservative approach minimizes side effects while establishing tolerability 1

Titration Schedule

• Increase by 5 mg/day every 2-3 days as tolerated
• Target the typical therapeutic dose of 15 mg/day (5 mg three times daily) within the first week 2
• Maximum dose: 60 mg/day (typically 20 mg three times daily), though most patients respond to 15-30 mg/day 1

Special Population Adjustments

Elderly Patients (≥65 years):

• Use the same starting dose of 5 mg twice daily
• No routine dose adjustment needed based on age alone 3
• Titrate more cautiously if multiple comorbidities or polypharmacy present

Hepatic Impairment:

• Avoid use in severe hepatic impairment - buspirone levels increase 15-fold with significantly prolonged half-life 4, 5
• If mild-moderate impairment, start at lower end and titrate slowly with close monitoring

Renal Impairment:

• Avoid use in severe renal impairment - buspirone levels double in renal dysfunction 4, 5
• Dose reduction required if creatinine clearance significantly reduced

Pediatric Patients:

• Safety and efficacy not established for generalized anxiety disorder in children 4
• If used off-label, doses of 7.5-30 mg twice daily have been studied, but higher plasma concentrations occur in children versus adults 6

Critical Timing Considerations

Onset of Effect

• Therapeutic effect requires 2-4 weeks to become fully apparent 1
• Counsel patients that buspirone is NOT for acute anxiety relief
• Unlike benzodiazepines, there is no immediate anxiolytic effect

Food Effects

• Administer consistently with or without food - food doubles both Cmax and AUC 5
• Inconsistent administration relative to meals causes variable drug exposure

Common Pitfalls to Avoid

1. Premature discontinuation: Patients may stop therapy before 2-4 weeks when benefits emerge 1

2. Expecting immediate relief: Buspirone is not appropriate for acute anxiety or PRN use - it requires continuous daily dosing 1

3. Inadequate dose: Many patients require 15-30 mg/day for optimal effect; stopping at 10 mg/day may result in treatment failure 1, 2

4. Drug interactions: Avoid concurrent use with strong CYP3A4 inhibitors (erythromycin, itraconazole, verapamil, diltiazem) which substantially increase buspirone levels 5

5. Laboratory interference: Discontinue buspirone 48 hours before urine catecholamine testing to avoid false-positive results for pheochromocytoma 4

6. Switching from benzodiazepines: Buspirone does NOT prevent benzodiazepine withdrawal - taper benzodiazepines separately while initiating buspirone

Monitoring Parameters

• Weeks 1-2: Assess tolerability (dizziness, drowsiness, nausea are most common) 4
• Week 4: Evaluate therapeutic response using anxiety rating scales
• Ongoing: Monitor for rare extrapyramidal symptoms or serotonin syndrome if combined with other serotonergic agents 4

The evidence consistently supports starting at 5 mg twice daily across multiple guidelines and the FDA label, with systematic titration to the 15-30 mg/day range where most patients achieve therapeutic benefit for mild-to-moderate anxiety 1, 4.